Compounds > tazolol
Page last updated: 2024-08-25

tazolol and Cancer of Liver

tazolol has been researched along with Cancer of Liver in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Guellaen, G; Hanoune, J; Lacombe, ML; Strosberg, AD; Vauquelin, G1

Other Studies

1 other study(ies) available for tazolol and Cancer of Liver

ArticleYear
Tazolol (1-isopropylamino-3-(2-thiazoloxy)-2-propanol) as a beta-adrenergic blocker.
    Biochemical pharmacology, 1976, Dec-01, Volume: 25, Issue:23

    Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Animals; Carcinoma, Hepatocellular; Female; In Vitro Techniques; Isoproterenol; Liver; Liver Neoplasms; Myocardium; Propanolamines; Rats; Stimulation, Chemical; Thiazoles

1976